aluates Reports

$ 0.0

Automative

Global Long-Acting Injectable (LAI) Antipsychotic Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-23S13896

Global Long Acting Injectable LAI Antipsychotic Market Research Report 2023

BUY CHAPTERS

Global Long-Acting Injectable (LAI) Antipsychotic Market Research Report 2025

Code: QYRE-Auto-23S13896

Report

April 2025

Pages:73

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Alkermes plc

Eli Lilly and Company

Janssen Global Services, LLC

Otsuka Pharmaceutical

Abilify Maintena

Haldol

Aristada

Prolixin

Sumitomo Dainippon Pharma

Long-Acting Injectable (LAI) Antipsychotic Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Long-Acting Injectable (LAI) Antipsychotic Market

The global market for Long-Acting Injectable (LAI) Antipsychotic was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Long-acting injectable (LAI) antipsychotics are a pharmacologic strategy for treating patients with schizophrenia who relapse due to nonadherence to antipsychotic medication.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Long-Acting Injectable (LAI) Antipsychotic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-Acting Injectable (LAI) Antipsychotic.

The Long-Acting Injectable (LAI) Antipsychotic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Long-Acting Injectable (LAI) Antipsychotic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Long-Acting Injectable (LAI) Antipsychotic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Long-Acting Injectable (LAI) Antipsychotic Market Report

Report Metric	Details
Report Name	Long-Acting Injectable (LAI) Antipsychotic Market
CAGR	5%
Segment by Type	Aripiprazole Fluphenazine Haloperidol Others
Segment by Application	Hospital Retail Pharmacy Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Alkermes, Eli Lilly and Company, Janssen Global Services, LLC, Abilify Maintena, Haldol, Otsuka Pharmaceutical, Aristada, Prolixin, Sumitomo Dainippon Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Long-Acting Injectable (LAI) Antipsychotic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Long-Acting Injectable (LAI) Antipsychotic Market report?

Ans: The main players in the Long-Acting Injectable (LAI) Antipsychotic Market are Alkermes, Eli Lilly and Company, Janssen Global Services, LLC, Abilify Maintena, Haldol, Otsuka Pharmaceutical, Aristada, Prolixin, Sumitomo Dainippon Pharma

What are the Application segmentation covered in the Long-Acting Injectable (LAI) Antipsychotic Market report?

Ans: The Applications covered in the Long-Acting Injectable (LAI) Antipsychotic Market report are Hospital, Retail Pharmacy, Others

What are the Type segmentation covered in the Long-Acting Injectable (LAI) Antipsychotic Market report?

Ans: The Types covered in the Long-Acting Injectable (LAI) Antipsychotic Market report are Aripiprazole, Fluphenazine, Haloperidol, Others

Recommended Reports

Antipsychotic Markets

Neurological Treatments

Injectable Drug Delivery

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Long-Acting Injectable (LAI) Antipsychotic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Aripiprazole

1.2.3 Fluphenazine

1.2.4 Haloperidol

1.2.5 Others

1.3 Market by Application

1.3.1 Global Long-Acting Injectable (LAI) Antipsychotic Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Retail Pharmacy

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Long-Acting Injectable (LAI) Antipsychotic Market Perspective (2020-2031)

2.2 Global Long-Acting Injectable (LAI) Antipsychotic Growth Trends by Region

2.2.1 Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Long-Acting Injectable (LAI) Antipsychotic Historic Market Size by Region (2020-2025)

2.2.3 Long-Acting Injectable (LAI) Antipsychotic Forecasted Market Size by Region (2026-2031)

2.3 Long-Acting Injectable (LAI) Antipsychotic Market Dynamics

2.3.1 Long-Acting Injectable (LAI) Antipsychotic Industry Trends

2.3.2 Long-Acting Injectable (LAI) Antipsychotic Market Drivers

2.3.3 Long-Acting Injectable (LAI) Antipsychotic Market Challenges

2.3.4 Long-Acting Injectable (LAI) Antipsychotic Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Long-Acting Injectable (LAI) Antipsychotic Players by Revenue

3.1.1 Global Top Long-Acting Injectable (LAI) Antipsychotic Players by Revenue (2020-2025)

3.1.2 Global Long-Acting Injectable (LAI) Antipsychotic Revenue Market Share by Players (2020-2025)

3.2 Global Long-Acting Injectable (LAI) Antipsychotic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Long-Acting Injectable (LAI) Antipsychotic Revenue

3.4 Global Long-Acting Injectable (LAI) Antipsychotic Market Concentration Ratio

3.4.1 Global Long-Acting Injectable (LAI) Antipsychotic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Long-Acting Injectable (LAI) Antipsychotic Revenue in 2024

3.5 Global Key Players of Long-Acting Injectable (LAI) Antipsychotic Head office and Area Served

3.6 Global Key Players of Long-Acting Injectable (LAI) Antipsychotic, Product and Application

3.7 Global Key Players of Long-Acting Injectable (LAI) Antipsychotic, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Long-Acting Injectable (LAI) Antipsychotic Breakdown Data by Type

4.1 Global Long-Acting Injectable (LAI) Antipsychotic Historic Market Size by Type (2020-2025)

4.2 Global Long-Acting Injectable (LAI) Antipsychotic Forecasted Market Size by Type (2026-2031)

5 Long-Acting Injectable (LAI) Antipsychotic Breakdown Data by Application

5.1 Global Long-Acting Injectable (LAI) Antipsychotic Historic Market Size by Application (2020-2025)

5.2 Global Long-Acting Injectable (LAI) Antipsychotic Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Long-Acting Injectable (LAI) Antipsychotic Market Size (2020-2031)

6.2 North America Long-Acting Injectable (LAI) Antipsychotic Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2020-2025)

6.4 North America Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Long-Acting Injectable (LAI) Antipsychotic Market Size (2020-2031)

7.2 Europe Long-Acting Injectable (LAI) Antipsychotic Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2020-2025)

7.4 Europe Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Size (2020-2031)

8.2 Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Size by Region (2020-2025)

8.4 Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Long-Acting Injectable (LAI) Antipsychotic Market Size (2020-2031)

9.2 Latin America Long-Acting Injectable (LAI) Antipsychotic Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2020-2025)

9.4 Latin America Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size (2020-2031)

10.2 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2020-2025)

10.4 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Alkermes

11.1.1 Alkermes Company Details

11.1.2 Alkermes Business Overview

11.1.3 Alkermes Long-Acting Injectable (LAI) Antipsychotic Introduction

11.1.4 Alkermes Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)

11.1.5 Alkermes Recent Development

11.2 Eli Lilly and Company

11.2.1 Eli Lilly and Company Company Details

11.2.2 Eli Lilly and Company Business Overview

11.2.3 Eli Lilly and Company Long-Acting Injectable (LAI) Antipsychotic Introduction

11.2.4 Eli Lilly and Company Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)

11.2.5 Eli Lilly and Company Recent Development

11.3 Janssen Global Services, LLC

11.3.1 Janssen Global Services, LLC Company Details

11.3.2 Janssen Global Services, LLC Business Overview

11.3.3 Janssen Global Services, LLC Long-Acting Injectable (LAI) Antipsychotic Introduction

11.3.4 Janssen Global Services, LLC Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)

11.3.5 Janssen Global Services, LLC Recent Development

11.4 Abilify Maintena

11.4.1 Abilify Maintena Company Details

11.4.2 Abilify Maintena Business Overview

11.4.3 Abilify Maintena Long-Acting Injectable (LAI) Antipsychotic Introduction

11.4.4 Abilify Maintena Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)

11.4.5 Abilify Maintena Recent Development

11.5 Haldol

11.5.1 Haldol Company Details

11.5.2 Haldol Business Overview

11.5.3 Haldol Long-Acting Injectable (LAI) Antipsychotic Introduction

11.5.4 Haldol Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)

11.5.5 Haldol Recent Development

11.6 Otsuka Pharmaceutical

11.6.1 Otsuka Pharmaceutical Company Details

11.6.2 Otsuka Pharmaceutical Business Overview

11.6.3 Otsuka Pharmaceutical Long-Acting Injectable (LAI) Antipsychotic Introduction

11.6.4 Otsuka Pharmaceutical Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)

11.6.5 Otsuka Pharmaceutical Recent Development

11.7 Aristada

11.7.1 Aristada Company Details

11.7.2 Aristada Business Overview

11.7.3 Aristada Long-Acting Injectable (LAI) Antipsychotic Introduction

11.7.4 Aristada Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)

11.7.5 Aristada Recent Development

11.8 Prolixin

11.8.1 Prolixin Company Details

11.8.2 Prolixin Business Overview

11.8.3 Prolixin Long-Acting Injectable (LAI) Antipsychotic Introduction

11.8.4 Prolixin Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)

11.8.5 Prolixin Recent Development

11.9 Sumitomo Dainippon Pharma

11.9.1 Sumitomo Dainippon Pharma Company Details

11.9.2 Sumitomo Dainippon Pharma Business Overview

11.9.3 Sumitomo Dainippon Pharma Long-Acting Injectable (LAI) Antipsychotic Introduction

11.9.4 Sumitomo Dainippon Pharma Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)

11.9.5 Sumitomo Dainippon Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Alkermes plc

Eli Lilly and Company

Janssen Global Services, LLC

Otsuka Pharmaceutical

Abilify Maintena

Haldol

Aristada

Prolixin

Sumitomo Dainippon Pharma

List of Tables

Table 1. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Aripiprazole

Table 3. Key Players of Fluphenazine

Table 4. Key Players of Haloperidol

Table 5. Key Players of Others

Table 6. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Long-Acting Injectable (LAI) Antipsychotic Market Share by Region (2020-2025)

Table 10. Global Long-Acting Injectable (LAI) Antipsychotic Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Long-Acting Injectable (LAI) Antipsychotic Market Share by Region (2026-2031)

Table 12. Long-Acting Injectable (LAI) Antipsychotic Market Trends

Table 13. Long-Acting Injectable (LAI) Antipsychotic Market Drivers

Table 14. Long-Acting Injectable (LAI) Antipsychotic Market Challenges

Table 15. Long-Acting Injectable (LAI) Antipsychotic Market Restraints

Table 16. Global Long-Acting Injectable (LAI) Antipsychotic Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Long-Acting Injectable (LAI) Antipsychotic Market Share by Players (2020-2025)

Table 18. Global Top Long-Acting Injectable (LAI) Antipsychotic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-Acting Injectable (LAI) Antipsychotic as of 2024)

Table 19. Ranking of Global Top Long-Acting Injectable (LAI) Antipsychotic Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Long-Acting Injectable (LAI) Antipsychotic Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Long-Acting Injectable (LAI) Antipsychotic, Headquarters and Area Served

Table 22. Global Key Players of Long-Acting Injectable (LAI) Antipsychotic, Product and Application

Table 23. Global Key Players of Long-Acting Injectable (LAI) Antipsychotic, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Long-Acting Injectable (LAI) Antipsychotic Revenue Market Share by Type (2020-2025)

Table 27. Global Long-Acting Injectable (LAI) Antipsychotic Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Long-Acting Injectable (LAI) Antipsychotic Revenue Market Share by Type (2026-2031)

Table 29. Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Long-Acting Injectable (LAI) Antipsychotic Revenue Market Share by Application (2020-2025)

Table 31. Global Long-Acting Injectable (LAI) Antipsychotic Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Long-Acting Injectable (LAI) Antipsychotic Revenue Market Share by Application (2026-2031)

Table 33. North America Long-Acting Injectable (LAI) Antipsychotic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Long-Acting Injectable (LAI) Antipsychotic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2026-2031) & (US$ Million)

Table 48. Alkermes Company Details

Table 49. Alkermes Business Overview

Table 50. Alkermes Long-Acting Injectable (LAI) Antipsychotic Product

Table 51. Alkermes Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025) & (US$ Million)

Table 52. Alkermes Recent Development

Table 53. Eli Lilly and Company Company Details

Table 54. Eli Lilly and Company Business Overview

Table 55. Eli Lilly and Company Long-Acting Injectable (LAI) Antipsychotic Product

Table 56. Eli Lilly and Company Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025) & (US$ Million)

Table 57. Eli Lilly and Company Recent Development

Table 58. Janssen Global Services, LLC Company Details

Table 59. Janssen Global Services, LLC Business Overview

Table 60. Janssen Global Services, LLC Long-Acting Injectable (LAI) Antipsychotic Product

Table 61. Janssen Global Services, LLC Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025) & (US$ Million)

Table 62. Janssen Global Services, LLC Recent Development

Table 63. Abilify Maintena Company Details

Table 64. Abilify Maintena Business Overview

Table 65. Abilify Maintena Long-Acting Injectable (LAI) Antipsychotic Product

Table 66. Abilify Maintena Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025) & (US$ Million)

Table 67. Abilify Maintena Recent Development

Table 68. Haldol Company Details

Table 69. Haldol Business Overview

Table 70. Haldol Long-Acting Injectable (LAI) Antipsychotic Product

Table 71. Haldol Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025) & (US$ Million)

Table 72. Haldol Recent Development

Table 73. Otsuka Pharmaceutical Company Details

Table 74. Otsuka Pharmaceutical Business Overview

Table 75. Otsuka Pharmaceutical Long-Acting Injectable (LAI) Antipsychotic Product

Table 76. Otsuka Pharmaceutical Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025) & (US$ Million)

Table 77. Otsuka Pharmaceutical Recent Development

Table 78. Aristada Company Details

Table 79. Aristada Business Overview

Table 80. Aristada Long-Acting Injectable (LAI) Antipsychotic Product

Table 81. Aristada Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025) & (US$ Million)

Table 82. Aristada Recent Development

Table 83. Prolixin Company Details

Table 84. Prolixin Business Overview

Table 85. Prolixin Long-Acting Injectable (LAI) Antipsychotic Product

Table 86. Prolixin Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025) & (US$ Million)

Table 87. Prolixin Recent Development

Table 88. Sumitomo Dainippon Pharma Company Details

Table 89. Sumitomo Dainippon Pharma Business Overview

Table 90. Sumitomo Dainippon Pharma Long-Acting Injectable (LAI) Antipsychotic Product

Table 91. Sumitomo Dainippon Pharma Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025) & (US$ Million)

Table 92. Sumitomo Dainippon Pharma Recent Development

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

Table 96. Authors List of This Report

List of Figures

Figure 1. Long-Acting Injectable (LAI) Antipsychotic Picture

Figure 2. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Long-Acting Injectable (LAI) Antipsychotic Market Share by Type: 2024 VS 2031

Figure 4. Aripiprazole Features

Figure 5. Fluphenazine Features

Figure 6. Haloperidol Features

Figure 7. Others Features

Figure 8. Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Long-Acting Injectable (LAI) Antipsychotic Market Share by Application: 2024 VS 2031

Figure 10. Hospital Case Studies

Figure 11. Retail Pharmacy Case Studies

Figure 12. Others Case Studies

Figure 13. Long-Acting Injectable (LAI) Antipsychotic Report Years Considered

Figure 14. Global Long-Acting Injectable (LAI) Antipsychotic Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Long-Acting Injectable (LAI) Antipsychotic Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Long-Acting Injectable (LAI) Antipsychotic Market Share by Region: 2024 VS 2031

Figure 17. Global Long-Acting Injectable (LAI) Antipsychotic Market Share by Players in 2024

Figure 18. Global Top Long-Acting Injectable (LAI) Antipsychotic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-Acting Injectable (LAI) Antipsychotic as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Long-Acting Injectable (LAI) Antipsychotic Revenue in 2024

Figure 20. North America Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Long-Acting Injectable (LAI) Antipsychotic Market Share by Country (2020-2031)

Figure 22. United States Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Long-Acting Injectable (LAI) Antipsychotic Market Share by Country (2020-2031)

Figure 26. Germany Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Share by Region (2020-2031)

Figure 34. China Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Long-Acting Injectable (LAI) Antipsychotic Market Share by Country (2020-2031)

Figure 42. Mexico Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Share by Country (2020-2031)

Figure 46. Turkey Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Alkermes Revenue Growth Rate in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)

Figure 50. Eli Lilly and Company Revenue Growth Rate in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)

Figure 51. Janssen Global Services, LLC Revenue Growth Rate in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)

Figure 52. Abilify Maintena Revenue Growth Rate in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)

Figure 53. Haldol Revenue Growth Rate in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)

Figure 54. Otsuka Pharmaceutical Revenue Growth Rate in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)

Figure 55. Aristada Revenue Growth Rate in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)

Figure 56. Prolixin Revenue Growth Rate in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)

Figure 57. Sumitomo Dainippon Pharma Revenue Growth Rate in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Long acting Injectable Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Long acting Antipsychotic Market Research Report 2024

Global Long Acting Schizophrenia Drug Market Research Report 2024

Global Psychiatric Long acting Injection Market Research Report 2024

Antipsychotics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Neuroleptics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antipsychotic Medications Market Research Report 2024

Global Anti schizophrenic Drugs Market Research Report 2025

Global Antipsychotic Drug Market Research Report 2024

Paliperidone Extended Release Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Atypical Antipsychotic Drugs Market Insights Forecast to 2030

Global Long acting Contraceptive Injection Market Research Report 2024

Risperidone Oral Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Injectable Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lithium Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Risperidone API Market Research Report 2025

Aripiprazole Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Psychiatric Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmaceutical Grade Paliperidone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions